Regional prophylaxis with teicoplanin in monolateral or bilateral total knee replacement: An open study

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 2, 2000, Pages 316-319

  De Lalla, Fausto ^a   Viola, Renato ^b,c   Pellizzer, Giampietro ^a   Lazzarini, Luca ^a   Tramarin, Andrea ^a   Fabris, Paolo ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

^b Hospital of Sandrigo   (Italy)

^c Ospedale Civile   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; TEICOPLANIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ESCHERICHIA COLI; FEMALE; GASTROENTERITIS; GRAFT INFECTION; HUMAN; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SALMONELLA ENTERITIDIS; TOTAL KNEE REPLACEMENT; TREATMENT FAILURE; TREATMENT OUTCOME; URINARY TRACT INFECTION; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ARTHROPLASTY, REPLACEMENT, KNEE; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PROSPECTIVE STUDIES; PROSTHESIS-RELATED INFECTIONS; TEICOPLANIN;

EID: 0033972070     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.2.316-319.2000     Document Type: Article

References (33)

1. Boyd, R. J., J. F. Burke, and T. Colton. 1973. A double blind clinical trial of prophylactic antibiotics in hip fracture. J. Bone Joint Surg. 55:1251-1258.
2. Brause, B. D. 1989. Infected orthopedic prostheses, p. 111-127. In A. L. Bisno and F. A. Waldvogel (ed.), Infections associated with indwelling medical devices. American Society for Microbiology, Washington, D.C.
3. Bryan, C. S., S. L. Morgan, R. J. Caton, and E. M. Lunceford. 1988. Cefazolin versus cefamandole for prophylaxis during total joint arthroplasty. Clin. Orthop. 228:117-122.
4. Campoli-Richards, D. M., R. N. Brogden, and D. Faulds. 1990. Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 40:449-486.
5. Carlsson, A. S., L. Lidgren, and L. Lindberg. 1977. Prophylactic antibiotics against early and late infections after total hip replacements. Acta Orthop. Scand. 48:405-410.
6. de Lalla, F., A. Novelli, G. P. Pellizzer, F. Milocchi, R. Viola, A. Rigon, C. Stecca, V. Dal Pizzol, S. Fallani, and P. Periti. 1993. Regional and systemic prophylaxis with teicoplanin in monolateral and bilateral total knee replacement procedures: study of pharmacokinetics and tissue penetration. Antimicrob. Agents Chemother. 37:2693-2698.
7. Eron, L. J. 1985. Prevention of infection following orthopaedic surgery. Antibiot. Chemother. 33:140-164.
8. Evrard, J., F. Doyon, J. F. Acar, J. C. Salord, F. Mazas, and R. Flamant. 1988. Two-day cefamandole versus five-day cephazolin prophylaxis in 965 total hip replacements. Report of a multicentre double blind randomized trial. Int. Orthop. 12:69-73.
9. Exner, K., E. Lang, A. Borsche, and G. Lemperle. 1992. Efficacy, tolerability and pharmacokinetics of teicoplanin in patients undergoing breast surgery. Eur. J. Surg. 567(Suppl.):33-38.
10. Gillespie, W. J. 1997. Prevention and management of infection after total joint replacement. Clin. Infect. Dis. 25:1310-1317.
11. Goodman, S. B., and D. J. Schurman. 1988. Prophylaxis in orthopedic surgery, p. 145-155. In D. Schlossberg (ed.), Orthopedic infection. Springer-Verlag, New York, N.Y.
12. Gorbach, S. L., R. E. Condon, J. E. Conte, Jr., A. B. Kaiser, W. J. Ledger, and R. L. Nichols. 1992. General guidelines for the evaluation of new antiinfective drugs for prophylaxis of surgical infections. Evaluations of new anti-infective drugs for surgical prophylaxis. Clin. Infect. Dis. 15(Suppl. 1): S313-S338.
13. Greenwood, C. 1988. Microbiological properties of teicoplanin. J. Antimicrob. Chemother. 21(Suppl. A):1-13.
14. Grogan, T. J., F. Dorey, J. Rollins, and H. C. Amstutz. 1986. Deep sepsis following total knee arthroplasty. Ten-year experience at the University of California at Los Angeles Medical Center. J. Bone Joint Surg. 68:226-234.
15. Ivey, F. M., C. A. Hicks, J. H. Calhoun, and J. T. Mader. 1990. Treatment options for infected knee arthroplasties: clinical reports. Rev. Infect. Dis. 12:468-478.
16. Lefrock, J. L., A. M. Ristuccia, P. A. Ristuccia, R. W. Quanzer, P. G. Haggerty, J. E. Allen, L. A. Lettau, R. Schwartz, and D. Appleby. 1992. Teicoplanin in the treatment of bone and joint infections. Eur. J. Surg. 567(Suppl.):9-13.
17. Marone, P., E. Concia, M. Andreonl, F. Suter, and M. Cruciani. 1990. Treatment of bone and soft tissue infections with teicoplanin. J. Antimicrob. Chemother. 25:435-439.
18. Mauerhan, D. R., C. L. Nelson, D. L. Smith, R. H. Fitzgerald, T. G. Slama, R. W. Petty, R. E. Jones, and R. P. Evans. 1994. Prophylaxis against infection in total joint arthroplasty. One day cefuroxime compared with three days of cefazoiin. J. Bone Joint. Surg. 76:39-45.
19. Nehrer, S., F. Thalhammer, E. Schwameis, and S. Breyer. 1998. Teicoplanin in the prevention of infection in total hip replacement. Arch. Orthop. Trauma Surg. 118:32-36.
20. Nelson, J. P., R. H. Fitzgerald, Jr., M. T. Jaspers, and J. W. Little. 1990. Prophylactic antimicrobial coverage in arthroplasty patients. J. Bone Joint Surg. 72:1.
21. Neu, H. C. 1984. Cephalosporin antibiotics as applied in surgery of bones and joints. Clin. Orthop. 190:50-64.
22. Nichols, R. L. 1994. Antibiotic prophylaxis in surgery. Curr. Opin. Infect. Dis. 7:647-652.
23. Norden, C. W. 1991. Antibiotic prophylaxis in orthopedic surgery. Rev. Infect. Dis. 13(Suppl. 10):S842-S846.
24. Oishi, C. S., W. V. Carrion, and F. T. Hoaglund. 1993. Use of parenteral prophylactic antibiotics in clean orthopaedic surgery. A review of the literature. Clin. Orthop. 296:249-255.
25. Paya, C. V., W. R. Wilson, and R. H. Fitzgerald, Jr. 1988. Management of infection in total knee replacement. Curr. Clin. Top. Infect. Dis. 9:222-240.
26. Periti, P., E. Mini, and G. Mosconi. 1998. Antimicrobial prophylaxis in orthopaedic surgery: the role of teicoplanin. J. Antimicrob. Chemother. 41:329-340.
27. Saravolatz, L. D. 1987. Infections in implantable prosthetic devices, p. 683-707. In R. P. Wenzel (ed.), Prevention and control of nosocomial infections. Williams & Wilkins, Baltimore, Md.
28. Suter, F., A. Avai, U. Fusco, M. Gerundini, S. Capriolo, and F. Maggiolo. 1994. Teicoplanin versus cefamandole in the prevention of total hip replacement. Eur. J. Clin. Microbiol. Infect. Dis. 13:793-796.
29. Taylor, G. J. S., G. C. Bannister, and S. Calder. 1990. Perioperative wound infection in elective orthopaedic surgery. J. Hosp. Infect. 16:241-247.
30. Wall, R., L. Kienerman, C. McCullough, and I. Fyfe. 1988. A comparison of teicoplanin and cefuroxime as prophylaxis for orthopaedic implant surgery: a preliminary report. J. Antimicrob. Chemother. 21(Suppl. A):141-146.
31. Wilson, A. P. R., B. Taylor, T. Treasure, R. N. Grunenberg, K. Patton, D. Felmingham, and M. F. Sturridge. 1988. Antibiotic prophylaxis in cardiac surgery: serum and tissue levels of teicoplanin, flucloxacillin and tobramycin. J. Antimicrob. Chemother. 21:201-212.
32. Wilson, P. D., Jr., E. A. Salvati, and E. L. Blumenfeld. 1975. The problem of infection in total prosthetic arthroplasty of the hip. Surg. Clin. N. Am. 55:1431-1445.
33. Young, E. J. 1990. Prevention of infection in prosthetic joints. Curr. Opin. Infect. Dis. 3:666-669.